Insulin syringe: difference between revisions
Diff·revision 13 → 14·11:45, 27 Dec 2024
Difference between revision 13 and revision 14 of Insulin syringe. 6 lines changed; the page grew by 130 bytes.
| Revision 13 — 06:12, 12 Dec 2024 StabilityStig (talk) add the shelf life after first puncture, attributed 3,647 bytes ±0 | Revision 14 — 11:45, 27 Dec 2024 SubQ_Solveig (talk) state that swirling rather than shaking is the handling convention, sourced 3,777 bytes +130 | ||
|---|---|---|---|
| 41 | <ref name="usp1503">United States Pharmacopeia, General Chapter <1503>, ''Quality Attributes of Synthetic Peptide Drug Substances''.</ref> | 41 | <ref name="usp1503">United States Pharmacopeia, General Chapter <1503>, ''Quality Attributes of Synthetic Peptide Drug Substances''.</ref> |
| 42 | 42 | ||
| + | 43 | == See also == | |
| + | 44 | * [[Insulin syringe unit conversion]] | |
| + | 45 | * [[Syringe dead space]] | |
| + | 46 | * [[Subcutaneous injection]] | |
| + | 47 | * [[Sharps disposal]] | |
| + | 48 | ||
| 43 | {{DEFAULTSORT:Insulin syringe}} | 49 | {{DEFAULTSORT:Insulin syringe}} |
| 44 | [[Category:Injection technique]] | 50 | [[Category:Injection technique]] |